» Articles » PMID: 38027298

Surfacing Undiagnosed Disease: Consideration, Counting and Coding

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2023 Nov 29
PMID 38027298
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnostic odyssey for people living with rare diseases (PLWRD) is often prolonged for myriad reasons including an initial failure to consider rare disease and challenges to systemically and systematically identifying and tracking undiagnosed diseases across the diagnostic journey. This often results in isolation, uncertainty, a delay to targeted treatments and increase in risk of complications with significant consequences for patient and family wellbeing. This article aims to highlight key time points to consider a rare disease diagnosis along with elements to consider in the potential operational classification for undiagnosed rare diseases during the diagnostic odyssey. We discuss the need to create a coding framework that traverses all stages of the diagnostic odyssey for PLWRD along with the potential benefits this will have to PLWRD and the wider community.

Citing Articles

Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.

Nurchis M, Radio F, Salmasi L, Heidar Alizadeh A, Raspolini G, Altamura G JAMA Netw Open. 2024; 7(1):e2353514.

PMID: 38277144 PMC: 10818217. DOI: 10.1001/jamanetworkopen.2023.53514.

References
1.
Bauskis A, Strange C, Molster C, Fisher C . The diagnostic odyssey: insights from parents of children living with an undiagnosed condition. Orphanet J Rare Dis. 2022; 17(1):233. PMC: 9206122. DOI: 10.1186/s13023-022-02358-x. View

2.
Bayram C, Harrison C, Charles J, Britt H . 'The kids are alright' - Changes in GP consultations with children 2000-15. Aust Fam Physician. 2016; 44(12):877-9. View

3.
Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E . "Is it going to hurt?": the impact of the diagnostic odyssey on children and their families. J Genet Couns. 2014; 24(2):325-35. DOI: 10.1007/s10897-014-9773-9. View

4.
Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A . The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis. 2022; 17(1):163. PMC: 9004040. DOI: 10.1186/s13023-022-02299-5. View

5.
Alonso V, Santos J, Pinto M, Ferreira J, Lema I, Lopes F . Health records as the basis of clinical coding: Is the quality adequate? A qualitative study of medical coders' perceptions. Health Inf Manag. 2019; 49(1):28-37. DOI: 10.1177/1833358319826351. View